Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Ventricular Assist Devices Market by Type (Right Ventricular Assist Devices (RVAD), Left Ventricular Assist Devices (LVAD), Bipolar Ventricular Assist Devices (BVAD)), By Application (Hospitals, Ambulatory Surgical Centers, Cardiology Centers) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Ventricular Assist Devices Market by Type (Right Ventricular Assist Devices (RVAD), Left Ventricular Assist Devices (LVAD), Bipolar Ventricular Assist Devices (BVAD)), By Application (Hospitals, Ambulatory Surgical Centers, Cardiology Centers) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 218514 3300 Pharma & Healthcare 377 249 Pages 4.9 (34)
                                          

The global ventricular assist devices market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of heart failure and the rising number of patients with end-stage heart disease. The increasing incidence of cardiovascular diseases in developing countries such as India and China is also expected to fuel the growth of this market during the forecast period. The right ventricular assist devices (RVAD) segment accounted for a share of over 50% in 2017, owing to its higher adoption rate among hospitals and cardiology centers for treating patients with end-stage heart disease. The left ventricular assist devices (LVAD) segment accounted for a share close to 30% in 2017, owing to its higher adoption rate among ambulatory surgical centers and cardiology centers for treating patients with end-stage heart disease. -The VAD market is expected to grow at a CAGR of 5.5% from 2017 to 2022, reaching $2.6 billion by 2022. -The VAD market is driven by factors such as increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in medical devices. -Increasing prevalence of chronic diseases such as diabetes mellitus and hypertension has led to an increase in the number of patients suffering from cardiovascular disease which has increased the demand for VADs globally. -Technological advancements have led to improved design and performance of VADs which has increased their adoption rates among physicians.

Industry Growth Insights published a new data on “Ventricular Assist Devices Market”. The research report is titled “Ventricular Assist Devices Market research by Types (Right Ventricular Assist Devices (RVAD), Left Ventricular Assist Devices (LVAD), Bipolar Ventricular Assist Devices (BVAD)), By Applications (Hospitals, Ambulatory Surgical Centers, Cardiology Centers), By Players/Companies Abiomed, Boston Scientific Corporation, Biotronik SE & Co. KG, LivaNova PLC, Medtronic plc, Berlin Heart, ReliantHeart, HeartWare International, Jarvik Heart, St. Jude Medical”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Ventricular Assist Devices Market Research Report

By Type

Right Ventricular Assist Devices (RVAD), Left Ventricular Assist Devices (LVAD), Bipolar Ventricular Assist Devices (BVAD)

By Application

Hospitals, Ambulatory Surgical Centers, Cardiology Centers

By Companies

Abiomed, Boston Scientific Corporation, Biotronik SE & Co. KG, LivaNova PLC, Medtronic plc, Berlin Heart, ReliantHeart, HeartWare International, Jarvik Heart, St. Jude Medical

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

249

Number of Tables & Figures

175

Customization Available

Yes, the report can be customized as per your need.


Global Ventricular Assist Devices Industry Outlook


Global Ventricular Assist Devices Market Report Segments:

The global Ventricular Assist Devices market is segmented on the basis of:

Types

Right Ventricular Assist Devices (RVAD), Left Ventricular Assist Devices (LVAD), Bipolar Ventricular Assist Devices (BVAD)

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospitals, Ambulatory Surgical Centers, Cardiology Centers

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Abiomed
  2. Boston Scientific Corporation
  3. Biotronik SE & Co. KG
  4. LivaNova PLC
  5. Medtronic plc
  6. Berlin Heart
  7. ReliantHeart
  8. HeartWare International
  9. Jarvik Heart
  10. St. Jude Medical

Global Ventricular Assist Devices Market Overview


Highlights of The Ventricular Assist Devices Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Right Ventricular Assist Devices (RVAD)
    2. Left Ventricular Assist Devices (LVAD)
    3. Bipolar Ventricular Assist Devices (BVAD)
  1. By Application:

    1. Hospitals
    2. Ambulatory Surgical Centers
    3. Cardiology Centers
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Ventricular Assist Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Ventricular Assist Devices Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


A ventricular assist device (VAD) is a medical device that helps to maintain blood flow in the brain. It is used when there is a lack of blood flow due to an illness or injury. VADs can help improve the quality of life for people who have suffered a stroke or other brain injury.

Some of the major players in the ventricular assist devices market are Abiomed, Boston Scientific Corporation, Biotronik SE & Co. KG, LivaNova PLC, Medtronic plc, Berlin Heart, ReliantHeart, HeartWare International, Jarvik Heart, St. Jude Medical.

The ventricular assist devices market is expected to grow at a compound annual growth rate of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Ventricular Assist Devices Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Ventricular Assist Devices Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Ventricular Assist Devices Market - Supply Chain
   4.5. Global Ventricular Assist Devices Market Forecast
      4.5.1. Ventricular Assist Devices Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Ventricular Assist Devices Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Ventricular Assist Devices Market Absolute $ Opportunity

5. Global Ventricular Assist Devices Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Ventricular Assist Devices Market Size and Volume Forecast by Type
      5.3.1. Right Ventricular Assist Devices (RVAD)
      5.3.2. Left Ventricular Assist Devices (LVAD)
      5.3.3. Bipolar Ventricular Assist Devices (BVAD)
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Ventricular Assist Devices Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Ventricular Assist Devices Market Size and Volume Forecast by Application
      6.3.1. Hospitals
      6.3.2. Ambulatory Surgical Centers
      6.3.3. Cardiology Centers
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Ventricular Assist Devices Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Ventricular Assist Devices Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Ventricular Assist Devices Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Ventricular Assist Devices Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Ventricular Assist Devices Demand Share Forecast, 2019-2026

9. North America Ventricular Assist Devices Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Ventricular Assist Devices Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Ventricular Assist Devices Market Size and Volume Forecast by Application
      9.4.1. Hospitals
      9.4.2. Ambulatory Surgical Centers
      9.4.3. Cardiology Centers
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Ventricular Assist Devices Market Size and Volume Forecast by Type
      9.7.1. Right Ventricular Assist Devices (RVAD)
      9.7.2. Left Ventricular Assist Devices (LVAD)
      9.7.3. Bipolar Ventricular Assist Devices (BVAD)
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Ventricular Assist Devices Demand Share Forecast, 2019-2026

10. Latin America Ventricular Assist Devices Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Ventricular Assist Devices Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Ventricular Assist Devices Market Size and Volume Forecast by Application
      10.4.1. Hospitals
      10.4.2. Ambulatory Surgical Centers
      10.4.3. Cardiology Centers
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Ventricular Assist Devices Market Size and Volume Forecast by Type
      10.7.1. Right Ventricular Assist Devices (RVAD)
      10.7.2. Left Ventricular Assist Devices (LVAD)
      10.7.3. Bipolar Ventricular Assist Devices (BVAD)
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Ventricular Assist Devices Demand Share Forecast, 2019-2026

11. Europe Ventricular Assist Devices Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Ventricular Assist Devices Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Ventricular Assist Devices Market Size and Volume Forecast by Application
      11.4.1. Hospitals
      11.4.2. Ambulatory Surgical Centers
      11.4.3. Cardiology Centers
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Ventricular Assist Devices Market Size and Volume Forecast by Type
      11.7.1. Right Ventricular Assist Devices (RVAD)
      11.7.2. Left Ventricular Assist Devices (LVAD)
      1.7.3. Bipolar Ventricular Assist Devices (BVAD)
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Ventricular Assist Devices Demand Share, 2019-2026

12. Asia Pacific Ventricular Assist Devices Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Ventricular Assist Devices Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Ventricular Assist Devices Market Size and Volume Forecast by Application
      12.4.1. Hospitals
      12.4.2. Ambulatory Surgical Centers
      12.4.3. Cardiology Centers
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Ventricular Assist Devices Market Size and Volume Forecast by Type
      12.7.1. Right Ventricular Assist Devices (RVAD)
      12.7.2. Left Ventricular Assist Devices (LVAD)
      12.7.3. Bipolar Ventricular Assist Devices (BVAD)
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Ventricular Assist Devices Demand Share, 2019-2026

13. Middle East & Africa Ventricular Assist Devices Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Ventricular Assist Devices Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Ventricular Assist Devices Market Size and Volume Forecast by Application
      13.4.1. Hospitals
      13.4.2. Ambulatory Surgical Centers
      13.4.3. Cardiology Centers
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Ventricular Assist Devices Market Size and Volume Forecast by Type
      13.7.1. Right Ventricular Assist Devices (RVAD)
      13.7.2. Left Ventricular Assist Devices (LVAD)
      13.7.3. Bipolar Ventricular Assist Devices (BVAD)
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Ventricular Assist Devices Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Ventricular Assist Devices Market: Market Share Analysis
   14.2. Ventricular Assist Devices Distributors and Customers
   14.3. Ventricular Assist Devices Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Abiomed
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Boston Scientific Corporation
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Biotronik SE & Co. KG
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. LivaNova PLC
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Medtronic plc
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Berlin Heart
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. ReliantHeart
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. HeartWare International
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Jarvik Heart
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. St. Jude Medical
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us